MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD Psychedelics Investing
Nutritional High Announces Completion of the Conversion of the 10% Senior Unsecured Convertible Debentures Cannabis Investing News
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn Pharmaceutical Investing
MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines Psychedelics Investing
Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip Device Medical Device Investing
Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease Medical Device Investing
BioHarvest Sciences Inc. Appoints Highly Acclaimed Advocate, Mr. Roberto Chait, to Company Advisory Board Biotech Investing
